NYTNYT·1hHealth
score-0.55
F.D.A. Panel Endorses Broader Peptide Access, Prompting Calls for Stronger Compounding Pharmacy Oversight
Original
F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
“Headlines use cautionary language ('raises concerns,' 'boom') to signal regulatory worry about market expansion with minimal oversight.”